Loading…
Based on limited metadata, the FDA issued a Warning Letter to Proandre SL, a drug manufacturer, on February 13, 2019. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. Additional documentation would be needed to identify the particular manufacturing, labeling, or compliance issues cited.